-
‘For sale’ sign could soon hang over Pfizer’s consumer healthcare business
NEW YORK — Pfizer on Tuesday might be putting its $3.4 billion consumer healthcare business on the sales block, noting that all scenarios would be considered during a strategic review of its options, which include a full or partial separation of the business from Pfizer through a spin-off, sale or other transaction.
Of course, Pfizer may ultimately determine to retain the business, the company added.
-
CityMD survey uncovers germiest places during flu season
NEW YORK — As flu season kicks off and the probability of catching the flu is a real concern, a majority of Americans admit to taking actions that may contribute to the spread of this highly contagious virus.
According to a new survey, roughly three out of five Americans who have had the flu or flu-like symptoms (61%) admitted to being out and about the last time they felt sick, putting others at risk, likely without them knowing.